TNFSF11 and endometrial cancer: In GSE17025, which was comprised of ninety-one samples of stage I human endometrial cancers (79 endometrioid and 12 serous) and twelve normal endometrium tissue specimens from surgery [26], the expression of RANKL was 2.15 times higher in endometrioid cancer than in normal tissues (Fig. 2B).